Status:
UNKNOWN
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics
Lead Sponsor:
Adistem Ltd
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether intravenous administration of autologous adipose-derived stem cells is of benefit in the management of types 2 diabetics.
Detailed Description
Diabetes Mellitus is of large epidemic proportions worldwide. It is proliferating at such a fast rate that new novel drugs and other therapeutic approaches are required. The purpose of this Phase 1/Ph...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Type II diabetes for at least 2 years
- Type 2 diabetics on oral hypoglycemic agents and/or insulin
- Fasting blood sugar of \>200mg% on at least two occasions
- Willing to keep a weekly diary and undergo observation for 12 months
Exclusion
- Presence of of previous and/or acute diabetic complications such as myocardial infarction, CVA or nephropathy
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00703612
Start Date
November 1 2007
End Date
January 1 2009
Last Update
July 1 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beverly Hills Medical Group
Makati City, Manila, Philippines, 1223
2
Veterens Memorial Medical Centre
Quezon City, Manila, Philippines, 1229